Carlson College of Veterinary Medicine

L. S. Young and Bermudez, L. E., “Perspective on animal models: chronic intracellular infections.”, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 33 Suppl 3, pp. S221-6, 2001.

L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G., “Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination.”, Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.

E. M. Foley-Thomas, Whipple, D. L., Bermudez, L. E., and Barletta, R. G., “Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis.”, Microbiology (Reading, England), vol. 141 ( Pt 5), pp. 1173-81, 1995.

L. E. Bermudez and Young, L. S., “Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.”, Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 20, no. 2, pp. 191-201, 1987.

J. A. McGarvey and Bermudez, L. E., “Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.”, Infection and immunity, vol. 69, no. 12, pp. 7242-9, 2001.

G. A. Cangelosi, Palermo, C. O., and Bermudez, L. E., “Phenotypic consequences of red-white colony type variation in Mycobacterium avium.”, Microbiology (Reading, England), vol. 147, no. Pt 3, pp. 527-33, 2001.

L. E. Bermudez, “[Post-antibiotic effect in the treatment of infections in neutropenic patients].”, Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.

L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., “Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”, The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.

L. E. Bermudez, “Potential role of cytokines in disseminated mycobacterial infections.”, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients.”, Research in microbiology, vol. 145, no. 3, pp. 206-9, 1994.

C. Hill, Pan, M., Babrak, L., Danelishvili, L., de Morais, H. Autran, and Bermudez, L. E., “Presence of Virulence-Associated Genes and Ability to Form Biofilm among Clinical Isolates of Causing Urinary Infection in Domestic Animals.”, Adv Microbiol, vol. 5, no. 8, pp. 573-579, 2015.

J. Champsi, Young, L. S., and Bermudez, L. E., “Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.”, Immunology, vol. 84, no. 4, pp. 549-54, 1995.

L. E. Bermudez, “Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.”, Journal of immunology (Baltimore, Md. : 1950), vol. 150, no. 5, pp. 1838-45, 1993.

L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S., “Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”, Cytokine, vol. 2, no. 4, pp. 287-93, 1990.

R. Rojony, Martin, M., Campeau, A., Wozniak, J. M., Gonzalez, D. J., Jaiswal, P., Danelishvili, L., and Bermudez, L. E., “Quantitative analysis of subsp proteome in response to antibiotics and during exposure to different environmental conditions.”, Clin Proteomics, vol. 16, p. 39, 2019.

L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.

L. E. Bermudez and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.”, Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.

L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”, The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.

L. E. Bermudez and Petrofsky, M., “Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells.”, Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.

N. Hsu, Young, L. S., and Bermudez, L. E., “Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex.”, Infection and immunity, vol. 63, no. 2, pp. 528-33, 1995.

L. E. Bermudez, Young, L. S., and Inderlied, C. B., “Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”, Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.

L. E. Bermudez, Goodman, J., and Petrofsky, M., “Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”, Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.

J. H. Champsi, Bermudez, L. E., and Young, L. S., “The role of cytokines in mycobacterial infection.”, Biotherapy (Dordrecht, Netherlands), vol. 7, no. 3-4, pp. 187-93, 1994.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Current pharmaceutical design, vol. 9, no. 1, pp. 61-5, 2003.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Curr Pharm Des, vol. 9, no. 1, pp. 61-5, 2003.